← Back to Companies

Vertex Pharmaceuticals Incorporated


Headquartered in Cambridge, MA, Vertex Pharmaceuticals Incorporated is a biotechnology company in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Telaprevir, a leading drug candidate, is an oral hepatitis C protease inhibitor and one of the most advanced of a new class of antiviral treatments in clinical development that target hepatitis C virus (HCV), infection.
(617) 444-6100
Boston, MA USA
Primary Address:
50 Northern Avenue
Boston, MA 2210
Parent Company:
Vertex Pharmaceuticals Incorporated

Employees (16)

NameTitleEmailPhone NumberSocial Media
S***** A*******Executive Vice President & Chief Commercial Officers*************[email protected](617) 444-****
(617) 961-****
H*** B****Senior Director, Global Marketing Brand Lead - SYMDEKOh********[email protected](617) 444-****
C****** C****Senior Director, Patient Engagementc***********[email protected](617) 444-****
N*** D*****Senior Vice President & Chief Communications Officern*********[email protected](617) 444-****
J******* G*******Senior Director, Market Access Hemej***************[email protected]
K**** K*****Director, US MarketingK**********[email protected]
S***** L********Senior Specialist, Marketing Operationss**************[email protected]
J****** L*****Chairman, President & Chief Executive Officer
M****** P********Senior Vice President, Investor Relationsm***************[email protected]
L**** P********Director, Procurement & Strategic Sourcingl*************[email protected]
K**** P*******Director, National Accounts Teamk************[email protected]
A*** S******Executive Vice President & Chief Regulatory Officera**********[email protected]
J*** S*******Vice President, Strategic Sourcing & Procurementj***********[email protected]
S**** S****Senior Directors*********[email protected]
M***** V****New Product Planning Lead, Type 1 Diabetes - Cell & Gene Therapiesm**********[email protected]
C****** W*****Executive Vice President & Chief Financial Officer
Last Updated on Jan 30, 2020